Trials / Completed
CompletedNCT04081857
A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects
A Randomized, Open-Label, Single-Dose, Crossover Study to Compare Pharmacokinetic Properties and Safety of HCP1704 and HGP1810 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
An open-label, randomized, single-dose crossover study to evaluate the pharmacokinetics and safety of HCP1704 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HGP1810 | HGP1810: Vildagliptin/Metformin |
| DRUG | HCP1704 | HCP1704: Vildagliptin/Metformin |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2019-08-05
- Completion
- 2019-08-05
- First posted
- 2019-09-09
- Last updated
- 2019-09-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04081857. Inclusion in this directory is not an endorsement.